Retraction: A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling [Molecular and Cellular Biology, 27, 21, (2007), (7486-7496)] Doi: 10.1128/MCB.00409-07;A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling

Molecular and Cellular Biology

Volumn 27, Issue 21, 2007, Pages 7486-7496

  Kitagawa, Hirochika ^a,b   Ray, William J ^a   Glantschnig, Helmut ^a   Nantermet, Pascale V ^a   Yu, Yuanjiang ^a   Leu, Chih Tai ^a   Harada, Shun Ichi ^a   Kato, Shigeaki ^b,c   Freedman, Leonard P ^a,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALSENILIN; DOPAMINE; LYMPHOID ENHANCER FACTOR 1; NUCLEAR RECEPTOR RELATED FACTOR 1; PRESENILIN 1; PRESENILIN 2; PROTEIN KCNIP4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MESENCEPHALON; MOUSE; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 35648989994     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00022-14     Document Type: Erratum

References (59)

1. Alimohamad, H., N. Rajakumar, Y. H. Seah, and W. Rushlow. 2005. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psych. 57:533-542.
2. Alimohamad, H., L. Sutton, J. Mouyal, N. Rajakumar, and W. J. Rushlow. 2005. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. J. Neurochem. 95:513-525.
3. Armogida, M., A. Petit, B. Vincent, S. Scarzello, C. A. da Costa, and F. Checler. 2001. Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat. Cell Biol 3:1030-1033.
4. Cadigan, K. M., and Y. I. Liu. 2006. Wnt signaling: complexity at the surface. J. Cell Sci. 119:395-402.
5. Castelo-Branco, G., and E. Arenas. 2006. Function of Wnts in dopaminergic neuron development. Neurodegener. Dis. 3:5-11.
6. Castelo-Branco, G., K. M. Sousa, V. Bryja, L. Pinto, J. Wagner, and E. Arenas. 2006. Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell. Neurosci. 31:251-262.
7. Castelo-Branco, G., J. Wagner, F. J. Rodriguez, J. Kele, K. Sousa, N. Rawal, H. A. Pasolli, E. Fuchs, J. Kitajewski, and E. Arenas. 2003. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. USA 100:12747-12752.
8. Castro, D. S., M. Arvidsson, M. Bondesson Bolin, and T. Perlmann. 1999. Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2. J. Biol. Chem. 274:37483-37490.
9. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
10. Chu, Y., K. Kompoliti, E. J. Cochran, E. J. Mufson, and J. H. Kordower. 2002. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol. 450:203-214.
11. Chu, Y., W. Le, K. Kompoliti, J. Jankovic, E. J. Mufson, and J. H. Kordower. 2006. Nurr1 in Parkinson's disease and related disorders. J. Comp. Neurol. 494:495-514.
12. Codina, A., G. Benoit, J. T. Gooch, D. Neuhaus, T. Perlmann, and J. W. Schwabe. 2004. Identification of a novel co-regulator interaction surface on the ligand binding domain of Nurr1 using NMR footprinting. J. Biol. Chem. 279:53338-53345.
13. Danielian, P. S., and A. P. McMahon. 1996. Engrailed-1 as a target of the Wnt-1 signalling pathway in vertebrate midbrain development. Nature 383:332-334.
14. Daniels, D. L., and W. I. Weis. 2005. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12:364-371.
15. Darragh, J., A. Soloaga, V. A. Beardmore, A. D. Wingate, G. R. Wiggin, M. Peggie, and J. S. Arthur. 2005. MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem. J. 390:749-759.
16. Dean, B. 2002. Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue. Postgrad. Med. J. 78:142-148.
17. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
18. Galleguillos, D., A. Vecchiola, J. A. Fuentealba, V. Ojeda, K. Alvarez, A. Gomez, and M. E. Andres. 2004. PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. J. Biol. Chem. 279:2005-2011.
19. Gould, T. D., and H. K. Manji. 2002. The Wnt signaling pathway in bipolar disorder. Neuroscientist 8:497-511.
20. Hermanson, E., B. Joseph, D. Castro, E. Lindqvist, P. Aarnisalo, A. Wallen, G. Benoit, B. Hengerer, L. Olson, and T. Perlmann. 2003. Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp. Cell Res. 288:324-334.
21. Holla, V. R., J. R. Mann, Q. Shi, and R. N. DuBois. 2006. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J. Biol. Chem. 281:2676-2682.
22. Jiang, C., X. Wan, Y. He, T. Pan, J. Jankovic, and W. Le. 2005. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp. Neurol. 191:154-162.
23. Joseph, B., A. Wallen-Mackenzie, G. Benoit, T. Murata, E. Joodmardi, S. Okret, and T. Perlmann. 2003. p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc. Natl. Acad. Sci. USA 100:15619-15624.
24. Kang, D. E., S. Soriano, X. Xia, C. G. Eberhart, B. De Strooper, H. Zheng, and E. H. Koo. 2002. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110:751-762.
25. Killick, R., C. C. Pollard, A. A. Asuni, A. K. Mudher, J. C. Richardson, H. T. Rupniak, P. W. Sheppard, I. M. Varndell, J. P. Brion, A. I. Levey, O. A. Levy, M. Vestling, R. Cowburn, S. Lovestone, and B. H. Anderton. 2001. Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. J. Biol. Chem. 276:48554-48561.
26. Kim, K. S., C. H. Kim, D. Y. Hwang, H. Seo, S. Chung, S. J. Hong, J. K. Lim, T. Anderson, and O. Isacson. 2003. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. J. Neurochem. 85:622-634.
27. Kim, S. Y., K. C. Choi, M. S. Chang, M. H. Kim, Y. S. Na, J. E. Lee, B. K. Jin, B. H. Lee, and J. H. Baik. 2006. The dopamine D2 receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. J. Neurosci. 26:4567-4576.
28. Kitagawa, H., R. Fujiki, K. Yoshimura, Y. Mezaki, Y. Uematsu, D. Matsui, S. Ogawa, K. Unno, M. Okubo, A. Tokita, T. Nakagawa, T. Ito, Y. Ishimi, H. Nagasawa, T. Matsumoto, J. Yanagisawa, and S. Kato. 2003. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917.
29. Kouzmenko, A. P., K. Takeyama, S. Ito, T. Furutani, S. Sawatsubashi, A. Maki, E. Suzuki, Y. Kawasaki, T. Akiyama, T. Tabata, and S. Kato. 2004. Wnt/beta-eatenin and estrogen signaling converge in vivo. J. Biol. Chem. 279:40255-40258.
30. Kozlovsky, N., S. Amar, R. H. Belmaker, and G. Agam. 2006. Psychotropic drugs affect Scr9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int. J. Neuropsychopharmacol. 9:337-342.
31. Le, W. D., P. Xu, J. Jankovic, H. Jiang, S. H. Appel, R. G. Smith, and D. K. Vassilatis. 2003. Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 33:85-89.
32. Liu, J., H. Wang, Y. Zuo, and S. R. Farmer. 2006. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol. Cell. Biol. 26:5827-5837.
33. Maira, M., C. Martens, E. Batsche, Y. Gauthier, and J. Drouin. 2003. Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol. Cell. Biol. 23:763-776.
34. Morohashi, Y., N. Hatano, S. Ohya, R. Takikawa, T. Watabiki, N. Takasugi, Y. Imaizumi, T. Tomita, and T. Iwatsubo. 2002. Molecular cloning and characterization of CALP/KCMP4, a novel EF-hand protein interacting with presenilin 2 and voltage-gated potassium channel subunit Kv4. J. Biol. Chem. 277:14965-14975.
35. Mulholland, D. J., S. Dedhar, G. A. Coetzee, and C. C. Nelson. 2005. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev. 26:898-915.
36. Murphy, E. P., and O. M. Conneely. 1997. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol. Endocrinol. 11:39-47.
37. Nantermet, P. V., J. Xu, Y. Yu, P. Hodor, D. Holder, S. Adamski, M. A. Gentile, D. B. Kimmel, S. Harada, D. Gerhold, L. P. Freedman, and W. J. Ray. 2004. Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J. Biol. Chem. 279:1310-1322.
38. Nordzell, M., P. Aarnisalo, G. Benoit, D. S. Castro, and T. Perlmann. 2004. Defining an N-terminal activation domain of the orphan nuclear receptor Nurr1. Biochem. Biophys. Res. Commun. 313:205-211.
39. Palaeino, J. J., M. P. Murphy, O. Murayama, K. Iwasaki, M. Fujiwara, A. Takashima, T. E. Golde, and B. Wolozin. 2001. Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion. J. Biol. Chem. 276:38563-38569.
40. Perissi, V., and M. G. Rosenfeld. 2005. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell. Biol. 6:542-554.
41. Porfiri, E., B. Rubinfeld, I. Albert, K. Hovanes, M. Waterman, and P. Polakis. 1997. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene 15:2833-2839.
42. Powzaniuk, M., S. McElwee-Witmer, R. L. Vogel, T. Hayami, S. J. Rutledge, F. Chen, S. Harada, A. Schmidt, G. A. Rodan, L. P. Freedman, and C. Bai. 2004. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. Mol. Endocrinol. 18:2011-2023.
43. Sacchetti, P., R. Carpentier, P. Segard, C. Olive-Cren, and P. Lefebvre. 2006. Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1. Nucleic Acids Res. 34:5515-5527.
44. Sacchetti, P., T. R. Mitchell, J. G. Granneman, and M. J. Bannon. 2001. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J. Neurochem. 76:1565-1572.
45. Sakurada, K., M. Ohshima-Sakurada, T. D. Palmer, and F. H. Gage. 1999. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126:4017-4026.
46. Salthun-Lassalle, B., E. C. Hirsch, J. Wolfart, M. Ruherg. and P. P. Michel. 2004. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J. Neurosci. 24:5922-5930.
47. Satoh, J., and Y. Kuroda. 2002. The constitutive and inducible expression of Nurr1, a key regulator of dopaminergic neuronal differentiation, in human neural and non-neural cell lines. Neuropathology 22:219-232.
48. Saucedo-Cardenas, O., J. D. Quintana-Hau, W. D. Le, M. P. Smidt, J. J. Cox, F. De Mayo, J. P. Burbach, and O. M. Conneely. 1998. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95:4013-4018.
49. Sierra, J., T. Yoshida, C. A. Joazeiro, and K. A. Jones. 2006. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 20:586-600.
50. Singh, R., J. N. Artaza, W. E. Taylor, M. Braga, X. Yuan, N. F. Gonzalez-Cadavid, and S. Bhasin. 2006. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147:141-154.
51. Soriano, S., D. E. Kang, M. Fu, R. Pestell, N. Chevallier, H. Zheng, and E. H. Koo. 2001. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J. Cell Biol. 152:785-794.
52. Takayama, S., I. Rogatsky, L. E. Schwarcz, and B. D. Darimont. 2006. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J. Biol. Chem. 281:17856-17863.
53. Volakakis, N., M. Malewicz, B. Kadkhodai, T. Perlmann, and G. Benoit. 2006. Characterization of the Nurr1 ligand-binding domain co-activator interaction surface. J. Mol. Endocrinol. 37:317-326.
54. Volpicelli, F., C. Perrone-Capano, P. Da Pozzo, L. Colucci-D'Amato, and U. di Porzio. 2004. Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones. J. Neurochem. 88:1283-1294.
55. Wang, Z., G. Benoit, J. Liu, S. Prasad, P. Aarnisalo, X. Liu, H. Xu, N. P. Walker, and T. Perlmann. 2003. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423:555-560.
56. Wansa, K. D., J. M. Harris, and G. E. Muscat 2002. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem. 277:33001-33011.
57. Xia, X., S. Qian, S. Soriano, Y. Wu, A. M. Fletcher, X. J. Wang, E. H. Koo, X. Wu, and H. Zheng. 2001. Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. USA 98:10863-10868.
58. Yanagisawa, J., H. Kitagawa, M. Yanagida, O. Wada, S. Ogawa, M. Nakagomi, H. Oishi, Y. Yamamoto, H. Nagasawa, S. B. McMahon, M. D. Cole, L. Tora, N. Takahashi, and S. Kato. 2002. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol. Cell 9:553-562.
59. Zetterstrom, R. H., L. Solomin, L. Janssen, B. J. Hoffer, L. Olson, and T. Perlmann. 1997. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276:248-250.